Improvement of HBsAg Gene-Modified Dendritic Cell-Based Vaccine Efficacy by Optimizing Immunization Method or the Application of β-glucosylceramide

Author： Long Jianting  

Publisher： Informa Healthcare

ISSN： 0882-0139

Source： Immunological Investigations, Vol.42, Iss.2, 2013-02, pp. : 137-155

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dendritic cell-based cancer immunotherapies

By Fujii Shin-ichiro  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 57, Iss. 3, 2009-06 ,pp. : 189-198

Springer Publishing Company

Access to resources Recommend Favorite

Viral vectors for dendritic cell-based immunotherapy

By Jenne L.   Schuler G.   Steinkasserer A.  

Trends in Immunology, Vol. 22, Iss. 2, 2001-02 ,pp. : 102-107

Elsevier

Access to resources Recommend Favorite

Dendritic Cell-based Immunotherapy for the Treatment of Hematological Malignancies

By Büchler Tomas   Michalek Jaroslav   Kovarova Lucie   Musilova Romana   Hajek Roman  

Hematology, Vol. 8, Iss. 2, 2003-01 ,pp. : 97-104

Maney Publishing

Access to resources Recommend Favorite

Liver Transplantation in HBsAg + Patients With Postoperative Immunoprophylaxis

By Langrehr J.M.   Guckelberger O.   Neumann U.   Berg T.   Schrem H.   Kratschmer B.   Knoop M.   Steinmuller T.   Lemmens H.P.   Keck H.   Bechstein W.O.   Neuhaus R.   Hopf U.   Neuhaus P.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2841-2842

Elsevier

Access to resources Recommend Favorite

Clinical Considerations in Developing Dendritic Cell Vaccine Based Immunotherapy Protocols in Cancer

By  

Current Molecular Medicine, Vol. 9, Iss. 6, 2009-08 ,pp. : 725-731

Bentham Science Publishers

Access to resources Recommend Favorite